Contakt

Oždian Tomáš Ph.D.

E-mail: tomas.ozdian@upol.cz
Phone: +420 585632067
Curriculum Vitae: download here

PhD student working on:

- Proteomics

- Liquid chromatography / mass spectrometry applications

- Western blot

- Proteomic response of cells to anticancer drugs

Publications (Impact Factor Journals)

  • [7]
    ŠKROTT, Z., M. MISTRÍK, K. ANDERSEN, S. FRIIS, D. MAJERA, J. GURSKÝ, T. OŽDIAN, J. BARTKOVA, Z. TURI, P. MOUDRÝ, M. KRAUS, M. MEDVEDÍKOVÁ, J. VÁCLAVKOVÁ, P. DŽUBÁK, I. VROBEL, P. POUCKOVA, J. SEDLACEK, A. MIKLOVICOVA, A. KUTT, J. MATTOVA, C. DRIESSEN, Q. DOU, J. OLSEN, M. HAJDÚCH, B. CVEK, R. DESHAIES a J. BÁRTEK. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature. 2017, 552(7684), 194-199. ISSN 0028-0836. IF: 40.137. PMID: 29211715
  • [6]
    OŽDIAN, T., D. HOLUB, Z. MACEČKOVÁ, L. VARANASI, G. RYLOVÁ, J. ŘEHULKA, J. VÁCLAVKOVÁ, H. SLAVÍK, P. MOUDRÝ, P. ZNOJEK, J. STANKOVÁ, J.B. DE SANCTIS, M. HAJDÚCH a P. DŽUBÁK. Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells. Journal of Proteomics. 2017, 162, 73-85. ISSN 1874-3919 . IF: 3.867. PMID: 28478306
  • [5]
    TICHÝ, M., S. SMOLEN, E. TLOUŠŤOVÁ, R. POHL, T. OŽDIAN, K. HEJTMÁNKOVÁ, B. LIŠKOVÁ, S. GURSKÁ, P. DŽUBÁK, M. HAJDÚCH a M. HOCEK. Synthesis and Cytostatic and Antiviral Profiling of Thieno-Fused 7-Deazapurine Ribonucleosides. Journal of Medicinal Chemistry. 2017, 60(6), 2411-2424. ISSN 0022-2623. IF: 5.589. PMID: 28221790
  • [4]
    ŠIMKOVÁ, D., G. KHARAISHVILI, G. KOŘÍNKOVÁ, T. OŽDIAN, T. SUCHANKOVA-KLEPLOVA, T. SOUKUP, M. KŘUPKA, A. GALANDÁKOVÁ, P. DŽUBÁK, M. JANÍKOVÁ, J. NAVRATIL, Z. KAHOUNOVA, K. SOUCEK a J. BOUCHAL. The dual role of asporin in breast cancer progression. Oncotarget. 2016, 7(32), 52045-52060. ISSN 1949-2553 . IF: 5.168. PMID: 27409832
  • [3]
    LIGASOVÁ, A., R. LIBOSKA, D. FRIEDECKÝ, K. MIČOVÁ, T. ADAM, T. OŽDIAN, I. ROSENBERG a K. KOBERNA. Dr Jekyll and Mr Hyde: A Strange Case of 5-Ethynyl-2'-deoxyuridine and 5-ethynyl-2'-deoxycytidine. Open Biology. 2016, 6: 150172, 1-11. ISSN 2046-2441. IF: 3.481. PMID: 26740587
  • [2]
    RYLOVÁ, G., T. OŽDIAN, L. VARANASI, M. SOURAL, J. HLAVÁČ, D. HOLUB, P. DŽUBÁK a M. HAJDÚCH. Affinity-Based Methods in Drug-Target Discovery. Current Drug Targets. 2015, 16(1), 60-76. ISSN 1389-4501. IF: 3.029. PMID: 25410410
  • [1]
    LEMROVÁ, B., P. SMYSLOVÁ, I. POPA, T. OŽDIAN, P. ZAJDEL a M. SOURAL. Directed Solid-Phase Synthesis of Trisubstituted Imidazo[4,5-c]pyridines and Imidazo[4,5-b]pyridines. ACS Combinatorial Science. 2014, 16(10), 558-565. ISSN 2156-8952. IF: 3.032. PMID: 25046560
  • Publications (Other Reviewed Journals)

  • [1]
    OŽDIAN, T., D. HOLUB, G. RYLOVÁ, J. VÁCLAVKOVÁ, M. HAJDÚCH a P. DŽUBÁK. Porovnání hmotnostně spektrometrických přístupů v proteomickém profilování léčiv. Chemagazín. 2016, 5, 8-11. ISSN 1210-7409.


  • Master students mentor:

    [5] Klára Brožová, Optimization and validation of FGF23 protein assay in FFPE samples,
    status: Ongoing, from: 2018
    [4] Pavlína Kalábová, Proteomics of the hair,
    status: Graduated, from: 2014 to 2018
    [3] Petra Zapletalová, Optimalization of intact protein mass spectrometry,
    status: Graduated, from: 2014 to 2016
    [2] Jarmila Stanková, Proteomic profile of CCRF-CEM cell line treated by 5-fluorouracil,
    status: Graduated, from: 2014 to 2016
    [1] Vendula Rašková, Proteomics of cervical fluid,
    status: Graduated, from: 2013 to 2016


    Bachelor students mentor:

    [3] Barbora Hamerníková, Optimization and validation of FGF23 protein assay in FFPE samples,
    status: Ongoing, from: 2018
    [2] Pavlína Kalábová, The validation of differentially expressed proteins in CCRF-CEM cell line treated by oxaliplatin,
    status: Graduated, from: 2013 to 2014
    [1] Jarmila Stanková, Determination of the efficacy of 5-fluorouracil on line CCRF-CEM T,
    status: Graduated, from: 2014